COMBINATORX CRXX (NASDAQ)

$ 3.40
19:09
Change: unch (unch%)
Volume: 274,774

Avg. Volume: 87034
P/E Ratio: 0
EPS (Annual): -1.97
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 34,850
Institutional Shareholders: 54.03%
Last: 3.40
Change: unch (unch%)
Prev. Close: 3.40
Open: 3.59
Day's Range: 3.35 - 3.72
52wk Range: 2.86 - 6.91
Market Value: 107,560
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: -49.85%
Total Return Last 3 Years: -65.63%
Total Return Last 5 Years: -56.69%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on CRXX
Alert me Subscribe

CombinatoRx 2Q loss grows on higher research costs

(CAMBRIDGE, Mass.)Biotech drug developer CombinatoRx Inc. said Wednesday its second-quarter loss widened as the company spent more money to develop its drug candidates Synavive and CRx-401 and reven...READ MORE
Aug 06, 2008 10:33AM
Keywords: CRXX, ANPI

Earnings Roundup: Blockbuster, Carrefour

Among the earnings stories for Thursday, March 6, from AP Financial News: DALLAS (AP) _ Blockbuster Inc., the movie rental company, said Thursday its fourth-quarter profit more tha...READ MORE
Mar 06, 2008 10:54AM
Keywords: BBI, RTRSY, TOC, GRB, USPH, CRXX, ALOG, CPK, CPHL

CombinatoRx Maintains 2008 Forecasts

(CAMBRIDGE, Mass.)Biotechnology company CombinatoRx Inc. said Thursday it still expects a full-year loss that is smaller than analysts' estimates. The company still predicts a 2008 loss between $49 ...READ MORE
Mar 06, 2008 9:33AM
Keywords: CRXX

CombinatoRx 4th-Quarter Loss Widens

(CAMBRIDGE, Mass.)CombinatoRx Inc. said Thursday its fourth-quarter loss widened on higher research and development expenses, but the results still beat analysts' estimates.READ MORE
Mar 06, 2008 9:33AM
Keywords: CRXX

CombinatoRx Shares Fall Despite Upgrade

(NEW YORK)Shares of drug developer CombinatoRx Inc. fell Thursday, even after Piper Jaffray upgraded the stock, citing a strong outlook for the company's developing arthritis treatments and ...READ MORE
Jan 03, 2008 7:59PM
Keywords: CRXX

Movers Roundup: Luminex, Sciele Pharma

Among the stock activity stories for Thursday, Jan. 3, from AP Financial News: WASHINGTON (AP) _ Shares of Luminex Corp., a biological testing company, jumped Thursday after federa...READ MORE
Jan 03, 2008 6:24PM
Keywords: LMNX, SCRX, CELG, PHRM, CRXX, ISIL

CombinatoRx Shares Rise on Piper Upgrade

(NEW YORK)Shares of drug developer CombinatoRx Inc. rose Thursday after Piper Jaffray upgraded the stock, citing a strong outlook for the company's developing arthritis treatments and partne...READ MORE
Jan 03, 2008 3:10PM
Keywords: CRXX
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +30.20 60.88
AMYLIN PHARMA I -55.90 21.48
GILEAD SCIENCES +22.60 49.98
BIOGEN IDEC INC -21.40 48.16
GENENTECH INC +33.70 96.50